Imaavy (Nipocalimab-aahu)

Medical Uses: Imaavy (nipocalimab-aahu) is a neonatal Fc receptor blocker used for the treatment of generalized myasthenia gravis (gMG) in adult and pediatric patients aged 12 years and older who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive.

Recommended Dosage:
The recommended initial dosage of Imaavy is 30 mg/kg administered once via intravenous (IV) infusion over at least 30 minutes. Two weeks after the initial dosage, administer a maintenance dosage of 15 mg/kg via intravenous (IV) infusion over at least 15 minutes. Continue the maintenance dosage every two weeks thereafter.
In case a scheduled infusion appointment is missed, the maintenance dosage should be administered as quickly as possible. Resume dosing every 2 weeks thereafter.

• The use of Imaavy 300 mg/1.62 mL or 1,200 mg/6.5 mL injection may place individuals at an increased risk for infections, some potentially severe. Symptoms such as fever, chills, or throat pain must be reported immediately. The physician may need to stop treatment and manage the infection with antibiotics.
• Some people will experience allergies with the use of this medicine. Signs of this may be rash, pruritus, swelling, and difficulty in breathing. If any of these symptoms occur, it is imprudent to take the drug, and instead, it is best to get emergency help. Apart from the severity of the reaction, doctors may decide not to restart the therapy.
  People are likely to have infusion related side effects which include, nausea, chills, fever, breathlessness etc. These symptoms occur during and soon after the procedure. The
• physician may reduce the rate of the infusion or provide non steroidal anti inflammatory drugs prior to the procedure to mitigate the likelihood of these sorts of reactions.
• This treatment affects other medications by either increasing or decreasing their potency. The doctor must be informed about all medications being taken, including dietary supplements and herbal medicines. The possibility of harmful effects may require close monitoring or alteration of the dose.
• This medicine may pose a risk to a fetus. Women of reproductive age should refrain from attempting to conceive during treatment and for some time after finishing the medicine. If a pregnancy is detected while using Imaavy, inform your medical professional without delay for proper management and care instructions.
• It is unknown whether Imaavy 300 mg/1.62 mL or 1,200 mg/6.5 mL injection is excreted in human milk. Women are advised against nursing during the period of treatment and after stopping the medication. This is to minimize the risk of causing any harm to the infant. Discuss safer options with your healthcare practitioner (HCP).
• The effects of this medicine on children have not been studied yet. It is not intended for use in minors. Doctors may explore alternative treatment strategies until sufficient evidence through clinical trials and subsequent approvals becomes accessible.

What documents are required to import IMAAVY to India?

IMAAVY (nipocalimab-aahu) injections can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

• The order will be confirmed only after the receipt of:
• A valid prescription from the Doctor
• Import permit if applicable

Is IMAAVY available in India?

IMAAVY (nipocalimab-aahu injections) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On availability of Imaavy in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

IMAAVY can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of IMAAVY (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Imaavy 300 mg/1.62 mL injection price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source IMAAVY (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Imaavy®?

Nipocalimab-aahu is a Generic Name for the trade name drug Imaavy®.

What is the Manufacturer's Name of Imaavy®?

Imaavy® is manufactured by Janssen Biotech, Inc.

Is Imaavy approved by the FDA?

Yes, Imaavy® is approved by the FDA. Date of first approval: April 29, 2025.

What is the dosage and form of Imaavy® supplied?

Imaavy is supplied for Injection: 300 mg/1.62 mL (185 mg/mL) & 1,200 mg/6.5 mL (185 mg/mL) in a single-dose vial for intravenous (IV) use.

What are the most common side effects of Imaavy® 185 mg/mL injections?

The most common side effects of Imaavy® injection are peripheral edema, respiratory tract infections, and muscle spasms.

How much does Imaavy® 185 mg/mL injection cost in India?

Prices of Imaavy injections may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Imaavy 185 mg/mL cost in India, please call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Imaavy® 185 mg/mL injections be available in SAARC countries?

Apart from Gulf countries, Imaavy® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Imaavy® injections in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Imaavy® 185 mg/mL injections online in India?

Yes, one can buy Imaavy 185 mg/mL online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the legal supply of Imaavy® injections through legal channels.

What are the storage conditions of Imaavy® 185 mg/mL injections?

Store vials refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light until the time of use. It is not advisable to freeze or shake the vials.